Pluri Inc. Logo

Pluri Inc.

Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.

PLUR | TA

Overview

Corporate Details

ISIN(s):
US72942G2030
LEI:
Country:
Israel
Address:
Park Building No. 5, 3508409 Haifa

Description

Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-10 00:23
Immediate Report
English 869.3 KB
2025-12-10 00:23
Immediate Report
English 36.5 KB
2025-12-09 16:31
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic S…
English 130.5 KB
2025-12-09 16:31
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic S…
English 36.4 KB
2025-12-09 00:29
Other Report or Announcement
English 283.7 KB
2025-12-09 00:29
Other Report or Announcement
English 36.5 KB
2025-12-09 00:26
Other Report or Announcement
English 163.6 KB
2025-12-09 00:26
Other Report or Announcement
English 36.5 KB
2025-12-09 00:25
Other Report or Announcement
English 165.1 KB
2025-12-09 00:25
Other Report or Announcement
English 36.4 KB
2025-12-09 00:23
Other Report or Announcement
English 163.4 KB
2025-12-09 00:23
Other Report or Announcement
English 36.4 KB
2025-12-09 00:22
Other Report or Announcement
English 163.7 KB
2025-12-09 00:22
Other Report or Announcement
English 36.4 KB
2025-12-09 00:21
Other Report or Announcement
English 163.3 KB

Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pluri Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pluri Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Binex Co., Ltd. Logo
Biopharmaceutical firm with pharma manufacturing and biologics CDMO services.
South Korea
053030
BioAge Labs, Inc. Logo
A clinical-stage biotech developing therapies for metabolic diseases by targeting aging.
United States of America
BIOA
BioAtla, Inc. Logo
Develops antibody-based therapeutics activated within the tumor microenvironment.
United States of America
BCAB
BIOBIJOU Co., Ltd. Logo
Develops and manufactures medical aesthetic products like H.A. fillers and skincare.
South Korea
489460
BioCardia, Inc. Logo
Develops cell-derived therapeutics for cardiovascular and pulmonary diseases.
United States of America
BCDA
Biocartis Group NV Logo
Develops and commercializes an automated molecular diagnostics platform for oncology.
Belgium
BCART
Bioceltix S.A. Logo
Develops stem cell-based medicinal products for veterinary use.
Poland
BCX
BIOCRYST PHARMACEUTICALS INC Logo
Develops novel medicines for patients with rare and serious diseases.
United States of America
BCRX
Biodexa Pharmaceuticals Plc Logo
Clinical-stage biopharma developing treatments for rare diseases, diabetes, and cancer.
United States of America
BDRX
Biofarm S.A. Logo
A pharmaceutical company that manufactures and markets medicines and dietary supplements.
Romania
BIO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.